Recombinant Human RGS4 Protein，His

RGS4, or Regulator of G-protein Signaling 4, is a member of the RGS protein family, which plays a crucial role in modulating G-protein-coupled receptor (GPCR) signaling pathways. GPCRs are involved in numerous physiological processes, making RGS proteins significant in the regulation of cellular responses to various stimuli. Research has shown that RGS4 negatively regulates G-protein signaling by accelerating the GTPase activity of Gα subunits, thereby promoting the transition from the active GTP-bound state back to the inactive GDP-bound state. Abnormal expression or function of RGS4 has been linked to various diseases, including psychiatric disorders, cardiovascular diseases, and cancer, highlighting its potential as a therapeutic target. The study of recombinant RGS4 protein has gained attention in both basic and applied research to elucidate its mechanisms in cell signaling and to explore its role in health and disease. Characterizing this protein through recombinant technology allows for detailed functional analyses, interaction studies with GPCRs, and the development of small-molecule modulators. Furthermore, understanding RGS4's structure-function relationship can illuminate the intricacies of G-protein signaling pathways and its implications in drug discovery. As a result, RGS4 recombinant protein research is pivotal in advancing our knowledge of cellular signaling and its impact on human health.